HeartBeat.bio
HeartBeat.bio is a privately funded drug discovery company focusing on the development of a high-throughput 3D screening platform.
HeartBeat.bio has raised €6.0M across 2 funding rounds from 5 investors, most recently a Seed round in Nov 2023. Based in Vienna, Austria; active in Healthtech. Data as of 28 Oct 2026.
Vienna, Austriaheartbeat-bio.eu ↗
Total raised
€6.0M
€6,000,000
Funding rounds
2
Investors
5
distinct backers
Active since
2021-05
latest 2023-11
Funding by year
EUR raised per yearHeartBeat.bio — funding by year — interactive chart.
Data table
| HeartBeat.bio — funding by year | |
|---|---|
| 2021 | €1.5M |
| 2023 | €4.5M |
Signals
High confidenceRaise-next likelihood9
base rate 44% for Seed
- ▼ Past typical raise window
- ▲ Up-round momentum
- ▼ Low backer re-investment
Exit likelihood8
base rate 11% (2+ rounds)
- ▲ 5y since founding (typical exit age)
- ▼ No recent equity round (debt-only or quiet)
Timing: overdue vs cohort gap · momentum up. Funding-only estimates, not predictions and not investment advice — see signals.
Funding rounds
2 rounds| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2023-11-02 | Seed | €4.5M | aws Gründungsfonds II,i&i Biotech Fund,Invest AG,Tensor Ventures | View deal → |
| 2021-05-04 | Seed | €1.5M | red-stars.com | View deal → |
Related news
Similar companies
same sector or country- Philips€2.6BNetherlands · Healthtech
- Isomorphic Labs€2.3BUK · Healthtech
- CMR Surgical€1.5BUK · Healthtech
- Roivant Sciences€1.1BSwitzerland · Healthtech
- Neko Health€924MSweden · Healthtech
- Oura Health€779MFinland · Healthtech
Global coverage: FundingData